Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Breast Cancer
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Breast Cancer
,
Pediatric Oncology
,
Multiple Myeloma
,
FDA Approvals, News & Updates
Read More ›
FDA Expands Indication for Kadcyla to Include the Adjuvant Treatment of HER2-Positive Early Breast Cancer
FDA Approvals, News & Updates
,
Breast Cancer
Read More ›
FDA Approves First Hormonal-Based Therapy for Men with Advanced or Metastatic Breast Cancer
Breast Cancer
,
FDA Approvals, News & Updates
Read More ›
Proposed Landmark Policy Changes to Modernize Mammography and Raise Breast Density Awareness
Breast Cancer
,
FDA Approvals, News & Updates
Read More ›
Practice-Changing Results: Adding Immunotherapy to Chemotherapy Extends Survival in Metastatic Triple-Negative Breast Cancer
Breast Cancer
,
Web Exclusives
Read More ›
Less Is More: 6 Months of Trastuzumab Treatment Equivalent to 12 Months in HER2-Positive Breast Cancer
Breast Cancer
,
Web Exclusives
Read More ›
First-in-Class Antibody-Drug Conjugate Effective in HER2-Negative Metastatic Breast Cancer
Breast Cancer
,
Web Exclusives
Read More ›
Chemotherapy Can Be Spared in Many Patients with Early Breast Cancer: Devil Is In the Details
Breast Cancer
,
Web Exclusives
Read More ›
Breaking News: Sellas Announces Promising Data on NeuVax in Combination with Herceptin in HER2 1+/2+ Breast Cancer
Breast Cancer
,
Web Exclusives
Read More ›
State of Personalized Medicine in Breast Cancer
By
Sarika Jain
;
Sachin G. Pai
;
Cesar A. Santa-Maria
;
William J. Gradishar
Breast Cancer
Read More ›
Page 1 of 2
1
2